<?xml version='1.0' encoding='utf8'?>
<text id="AMALGUM_academic_transplant" title="Obesity in the Liver Transplant Setting" shortTitle="transplant" author="Carlos Moctezuma-Velazquez, Ernesto Márquez-Guillén, Aldo Torre" type="academic" dateCollected="2019-11-03" sourceURL="https://www.mdpi.com/2072-6643/11/11/2552/htm" speakerList="none" speakerCount="0">
<head>
<s type="frag">
2.	LS	2.
Obesity	NN	obesity
Before	IN	before
Liver	NN	liver
Transplantation	NN	Transplantation
</s>
</head>
<head>
<s type="wh">
2.1.	MD	2.1.
How	WRB	how
Should	MD	should
Obesity	NN	obesity
be	VB	be
Defined	VBN	Define
in	IN	in
Patients	NNS	patient
with	IN	with
Cirrhosis	NN	cirrhosis
Considered	VBN	consider
for	IN	for
LT	NNP	LT
?	.	?
</s>
</head>
<p>
<s type="decl">
The	DT	the
first	JJ	first
obstacle	NN	obstacle
is	VBZ	be
to	TO	to
define	VB	define
obesity	NN	obesity
in	IN	in
this	DT	this
population	NN	population
.	.	.
</s>
<s type="decl">
Elamparast	NNP	Elamparast
et	FW	et
al.	FW	al.
recently	RB	recently
summarized	VBD	summarize
the	DT	the
most	RBS	most
commonly	RB	commonly
used	VBN	use
definitions	NNS	definition
in	IN	in
this	DT	this
group	NN	group
of	IN	of
patients	NNS	patient
:	:	:
</s>
</p>
<s type="frag">
<dl class="html-bullet">
<dt id="">
-	:	-
</dt>
<dd>
BMI	NNP	BMI
≥	FW	≥
30	CD	30
kg/m2	NN	kg/m2
(	-LRB-	(
Asian	JJ	Asian
population	NN	population
:	:	:
≥25	CD	≥25
kg/m2	NN	kg/m2
)	-RRB-	)
;	:	;
</dd>
<dt id="">
-	:	-
</dt>
<dd>
Percentage	NN	percentage
of	IN	of
fat	NN	fat
mass	NN	mass
≥28	CD	≥28
%	NN	%
in	IN	in
men	NNS	man
and	CC	and
≥40	CD	≥40
%	NN	%
in	IN	in
women	NNS	woman
;	:	;
</dd>
<dt id="">
-	:	-
</dt>
<dd>
Waist	NN	waist
circumference	NN	circumference
˃102	CD	˃102
cm	NNS	centimeter
in	IN	in
men	NNS	man
and	CC	and
˃88	CD	˃88
cm	NNS	centimeter
in	IN	in
women	NNS	woman
(	-LRB-	(
Asian	JJ	Asian
population	NN	population
:	:	:
A	DT	a
waist	NN	waist
circumference	NN	circumference
˃90	CD	˃90
cm	NNS	centimeter
in	IN	in
men	NNS	man
and	CC	and
˃80	CD	˃80
cm	NNS	centimeter
in	IN	in
women	NNS	woman
)	-RRB-	)
;	:	;
</dd>
<dt id="">
-	:	-
</dt>
<dd>
Visceral	JJ	Visceral
fat	NN	fat
area	NN	area
≥100	CD	≥100
cm2	NN	cm2
on	IN	on
abdominal	JJ	abdominal
computed	VBN	compute
tomography	NN	tomography
.	.	.
</dd>
</dl>
</s>
<p>
<s type="decl">
The	DT	the
use	NN	use
of	IN	of
BMI	NNP	BMI
has	VBZ	have
several	JJ	several
limitations	NNS	limitation
in	IN	in
patients	NNS	patient
with	IN	with
decompensated	JJ	decompensated
cirrhosis	NN	cirrhosis
,	,	,
as	IN	as
reflected	VBN	reflect
by	IN	by
the	DT	the
fact	NN	fact
that	IN	that
sarcopenia	NN	sarcopenia
outperforms	VBZ	outperform
BMI	NNP	BMI
as	IN	as
a	DT	a
predictor	NN	predictor
of	IN	of
outcomes	NNS	outcome
after	IN	after
LT	NNP	LT
.	.	.
</s>
<s type="decl">
First	RB	first
of	IN	of
all	DT	all
,	,	,
a	DT	a
high	JJ	high
BMI	NN	BMI
may	MD	may
be	VB	be
due	JJ	due
to	IN	to
fluid	NN	fluid
overload/ascites	NNS	overload/ascite
,	,	,
and	CC	and
not	RB	not
obesity	NN	obesity
per	IN	per
se	NN	se
,	,	,
as	IN	as
exemplified	VBN	exemplify
in	IN	in
a	DT	a
study	NN	study
in	IN	in
which	WDT	which
adjusting	VBG	adjust
BMI	NN	BMI
for	IN	for
the	DT	the
liters	NNS	liter
of	IN	of
ascites	NNS	ascite
drained	VBN	drain
at	IN	at
the	DT	the
time	NN	time
of	IN	of
LT	NNP	LT
resulted	VBD	result
in	IN	in
moving	VBG	move
one-fifth	NN	one-fifth
of	IN	of
patients	NNS	patient
from	IN	from
one	CD	one
BMI	NN	BMI
category	NN	category
to	IN	to
a	DT	a
lower	JJR	low
one	CD	one
.	.	.
</s>
<s type="decl">
Also	RB	also
,	,	,
BMI	NNP	BMI
gives	VBZ	give
no	DT	no
information	NN	information
about	IN	about
body	NN	body
composition	NN	composition
:	:	:
It	PRP	it
cannot	MD	cannot
tell	VB	tell
the	DT	the
difference	NN	difference
between	IN	between
muscle	NN	muscle
,	,	,
subcutaneous	JJ	subcutaneous
,	,	,
or	CC	or
visceral	JJ	visceral
adipose	NN	adipose
tissue	NN	tissue
,	,	,
which	WDT	which
have	VBP	have
different	JJ	different
implications	NNS	implication
.	.	.
</s>
<s type="decl">
Studies	NNS	Study
looking	VBG	look
at	IN	at
body	NN	body
composition	NN	composition
on	IN	on
cross-sectional	JJ	cross-sectional
imaging	NN	imaging
have	VBP	have
found	VBN	find
that	IN	that
sarcopenia	NN	sarcopenia
and	CC	and
low	JJ	low
subcutaneous	JJ	subcutaneous
adipose	NN	adipose
tissue	NN	tissue
,	,	,
but	CC	but
not	RB	not
BMI	NN	BMI
,	,	,
are	VBP	be
associated	VBN	associate
with	IN	with
mortality	NN	mortality
in	IN	in
male	JJ	male
and	CC	and
female	JJ	female
patients	NNS	patient
with	IN	with
cirrhosis	NN	cirrhosis
,	,	,
respectively	RB	respectively
.	.	.
</s>
<s type="decl">
Excessive	JJ	Excessive
visceral	JJ	visceral
fat	NN	fat
when	WRB	when
associated	VBN	associate
with	IN	with
sarcopenia	NN	sarcopenia
,	,	,
a	DT	a
term	NN	term
known	VBN	know
as	IN	as
sarcopenic	JJ	sarcopenic
obesity	NN	obesity
,	,	,
is	VBZ	be
also	RB	also
associated	VBN	associate
with	IN	with
increased	VBN	increase
mortality	NN	mortality
.	.	.
</s>
<s type="decl">
In	IN	in
the	DT	the
case	NN	case
of	IN	of
living	JJ	live
donor	NN	donor
liver	NN	liver
transplant	NN	transplant
(	-LRB-	(
LDLT	NNP	LDLT
)	-RRB-	)
patients	NNS	patient
,	,	,
sarcopenia	NN	sarcopenia
,	,	,
myosteatosis	NN	myosteatosis
,	,	,
and	CC	and
the	DT	the
visceral-to-subcutaneous-adipose-tissue	JJ	visceral-to-subcutaneous-adipose-tissue
ratio	NN	ratio
,	,	,
but	CC	but
not	RB	not
visceral	JJ	visceral
or	CC	or
subcutaneous	JJ	subcutaneous
tissue	NN	tissue
on	IN	on
their	PRP$	their
own	JJ	own
,	,	,
have	VBP	have
been	VBN	be
associated	VBN	associate
with	IN	with
mortality	NN	mortality
.	.	.
</s>
<s type="decl">
This	DT	this
reinforces	VBZ	reinforce
the	DT	the
fact	NN	fact
that	IN	that
more	RBR	more
than	IN	than
the	DT	the
size	NN	size
of	IN	of
a	DT	a
patient	NN	patient
,	,	,
which	WDT	which
is	VBZ	be
what	WP	what
the	DT	the
BMI	NNP	BMI
stands	VBZ	stand
for	IN	for
,	,	,
it	PRP	it
is	VBZ	be
the	DT	the
composition	NN	composition
that	WDT	that
matters	VBZ	matter
.	.	.
</s>
<s type="decl">
For	IN	for
the	DT	the
same	JJ	same
reasons	NNS	reason
,	,	,
waist	NN	waist
circumference	NN	circumference
is	VBZ	be
not	RB	not
the	DT	the
best	JJS	good
method	NN	method
to	TO	to
assess	VB	assess
obesity	NN	obesity
in	IN	in
these	DT	this
patients	NNS	patient
.	.	.
</s>
<s type="decl">
Trying	VBG	try
to	TO	to
circumvent	VB	circumvent
some	DT	some
of	IN	of
these	DT	this
limitations	NNS	limitation
,	,	,
the	DT	the
European	NNP	European
Association	NNP	Association
for	IN	for
the	DT	the
Study	NNP	Study
of	IN	of
the	DT	the
Liver	NNP	Liver
guidelines	NNS	guideline
for	IN	for
nutrition	NN	nutrition
in	IN	in
patients	NNS	patient
with	IN	with
cirrhosis	NN	cirrhosis
recommend	VBP	recommend
to	TO	to
adjust	VB	adjust
the	DT	the
BMI	NN	BMI
for	IN	for
the	DT	the
confounding	JJ	confounding
effect	NN	effect
of	IN	of
fluid	NN	fluid
retention	NN	retention
(	-LRB-	(
i.e.	FW	i.e.
,	,	,
dry-BMI	NNP	dry-BMI
)	-RRB-	)
,	,	,
though	IN	though
there	EX	there
is	VBZ	be
no	DT	no
perfect	JJ	perfect
correlation	NN	correlation
between	IN	between
BMI	NN	BMI
and	CC	and
ascites	NNS	ascite
,	,	,
and	CC	and
in	IN	in
fact	NN	fact
,	,	,
BMI	NNP	BMI
corrected	VBN	correct
for	IN	for
ascites	NNS	ascite
drained	VBN	drain
at	IN	at
the	DT	the
time	NN	time
of	IN	of
LT	NNP	LT
failed	VBD	fail
to	TO	to
predict	VB	predict
relevant	JJ	relevant
outcomes	NNS	outcome
after	IN	after
LT	NNP	LT
.	.	.
</s>
<s type="decl">
Likewise	RB	likewise
,	,	,
a	DT	a
modified	VBN	modify
BMI	NN	BMI
calculated	VBN	calculate
by	IN	by
multiplying	VBG	multiply
BMI	NNP	BMI
(	-LRB-	(
kg/m2	NN	kg/m2
)	-RRB-	)
by	IN	by
serum	NN	serum
albumin	NN	albumin
(	-LRB-	(
g/L	NN	g/L
)	-RRB-	)
with	IN	with
the	DT	the
intention	NN	intention
of	IN	of
compensating	VBG	compensate
for	IN	for
volume	NN	volume
overload	NN	overload
was	VBD	be
found	VBN	find
of	IN	of
no	DT	no
use	NN	use
to	TO	to
predict	VB	predict
clinical	JJ	clinical
outcomes	NNS	outcome
.	.	.
</s>
</p>
<p>
<s type="decl">
In	IN	in
conclusion	NN	conclusion
,	,	,
when	WRB	when
available	JJ	available
,	,	,
we	PRP	we
suggest	VBP	suggest
obesity	NN	obesity
be	VB	be
defined	VBN	define
according	VBG	accord
to	IN	to
the	DT	the
visceral	JJ	visceral
fat	JJ	fat
area	NN	area
on	IN	on
body	NN	body
composition	NN	composition
analysis	NN	analysis
,	,	,
especially	RB	especially
in	IN	in
the	DT	the
research	NN	research
setting	NN	setting
,	,	,
because	IN	because
the	DT	the
impact	NN	impact
of	IN	of
obesity	NN	obesity
on	IN	on
LT	NNP	LT
may	MD	may
be	VB	be
modified	VBN	modify
by	IN	by
the	DT	the
coexistence	NN	coexistence
of	IN	of
sarcopenia	NN	sarcopenia
,	,	,
myosteatosis	NN	myosteatosis
,	,	,
and/or	CC	and/or
low	JJ	low
subcutaneous	JJ	subcutaneous
adipose	NN	adipose
tissue	NN	tissue
.	.	.
</s>
</p>
<head>
<s type="q">
2.2.	CD	2.2.
Should	MD	should
Morbidly	NNP	morbidly
Obese	JJ	Obese
Patients	NNS	patient
be	VB	be
Listed	VBN	list
for	IN	for
LT	NNP	LT
?	.	?
</s>
</head>
<p>
<s type="decl">
Some	DT	some
LT	NNP	LT
programs	NNS	program
consider	VBP	consider
morbid	JJ	morbid
obesity	NN	obesity
a	DT	a
relative	JJ	relative
contraindication	NN	contraindication
for	IN	for
LT	NNP	LT
based	VBN	base
on	IN	on
the	DT	the
latest	JJS	late
recommendations	NNS	recommendation
from	IN	from
the	DT	the
American	NNP	American
Association	NNP	Association
for	IN	for
the	DT	the
Study	NNP	Study
of	IN	of
the	DT	the
Liver	NNP	Liver
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
evidence	NN	evidence
evaluating	VBG	evaluate
the	DT	the
role	NN	role
of	IN	of
obesity	NN	obesity
on	IN	on
outcomes	NNS	outcome
after	IN	after
LT	NNP	LT
is	VBZ	be
conflicting	JJ	conflicting
.	.	.
</s>
<s type="decl">
When	WRB	when
needed	VBN	need
,	,	,
patients	NNS	patient
with	IN	with
severe	JJ	severe
and	CC	and
morbid	JJ	morbid
obesity	NN	obesity
do	VBP	do
benefit	VB	benefit
from	IN	from
LT	NN	LT
,	,	,
meaning	VBG	mean
they	PRP	they
live	VBP	live
longer	RBR	long
than	IN	than
they	PRP	they
would	MD	would
do	VB	do
without	IN	without
it	PRP	it
,	,	,
and	CC	and
LT	NN	LT
in	IN	in
these	DT	this
patients	NNS	patient
strays	VBZ	stray
far	RB	far
away	RB	away
from	IN	from
being	VBG	be
futile	JJ	futile
,	,	,
with	IN	with
five-year	JJ	five-year
survival	NN	survival
rates	NNS	rate
well	RB	well
above	IN	above
50	CD	50
%	NN	%
.	.	.
</s>
<s type="decl">
Evidence	NN	evidence
so	RB	so
far	RB	far
does	VBZ	do
not	RB	not
support	VB	support
using	VBG	use
a	DT	a
strict	JJ	strict
BMI	NN	BMI
cutoff	NN	cutoff
to	TO	to
deny	VB	deny
someone	NN	someone
candidacy	NN	candidacy
for	IN	for
LT	NNP	LT
,	,	,
however	RB	however
obesity	NN	obesity
is	VBZ	be
frequently	RB	frequently
associated	VBN	associate
with	IN	with
other	JJ	other
conditions	NNS	condition
that	WDT	that
may	MD	may
be	VB	be
contraindications	NNS	contraindication
for	IN	for
LT	NN	LT
such	JJ	such
as	IN	as
cardiovascular	JJ	cardiovascular
disease	NN	disease
,	,	,
cancer	NN	cancer
,	,	,
renal	JJ	renal
dysfunction	NN	dysfunction
,	,	,
and	CC	and
pulmonary	JJ	pulmonary
hypertension	NN	hypertension
.	.	.
</s>
<s type="decl">
Also	RB	also
,	,	,
obesity	NN	obesity
is	VBZ	be
a	DT	a
risk	NN	risk
factor	NN	factor
for	IN	for
NAFLD	NNP	NAFLD
,	,	,
which	WDT	which
though	IN	though
traditionally	RB	traditionally
considered	VBN	consider
to	TO	to
have	VB	have
similar	JJ	similar
post-LT	JJ	post-LT
outcomes	NNS	outcome
to	IN	to
those	DT	this
of	IN	of
other	JJ	other
etiologies	NNS	etiology
of	IN	of
liver	NN	liver
disease	NN	disease
,	,	,
may	MD	may
in	IN	in
fact	NN	fact
have	VB	have
lower	JJR	low
one-year	JJ	one-year
survival	NN	survival
due	JJ	due
to	IN	to
cardiovascular	JJ	cardiovascular
and	CC	and
cerebrovascular	JJ	cerebrovascular
diseases	NNS	disease
.	.	.
</s>
<s type="decl">
In	IN	in
summary	NN	summary
,	,	,
more	RBR	more
than	IN	than
obesity	NN	obesity
itself	PRP	itself
,	,	,
it	PRP	it
is	VBZ	be
the	DT	the
sum	NN	sum
of	IN	of
the	DT	the
comorbidities	NNS	comorbidity
of	IN	of
the	DT	the
individual	JJ	individual
patient	NN	patient
that	WDT	that
determines	VBZ	determine
LT	NNP	LT
outcomes	NNS	outcome
and	CC	and
as	RB	as
such	JJ	such
,	,	,
morbid	JJ	morbid
obesity	NN	obesity
should	MD	should
not	RB	not
be	VB	be
considered	VBN	consider
on	IN	on
its	PRP$	its
own	JJ	own
a	DT	a
contraindication	NN	contraindication
for	IN	for
LT	NNP	LT
,	,	,
but	CC	but
in	IN	in
turn	NN	turn
should	MD	should
trigger	VB	trigger
a	DT	a
rigorous	JJ	rigorous
pre-LT	JJ	pre-LT
assessment	NN	assessment
to	TO	to
carefully	RB	carefully
select	VB	select
potential	JJ	potential
recipients	NNS	recipient
,	,	,
as	IN	as
discussed	VBN	discuss
below	RB	below
.	.	.
</s>
</p>
</text>